Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,453 | -12,519 | -9,962 | -6,751 | -3,102 |
| Depreciation Amortization | 35 | 187 | 150 | 85 | 25 |
| Accounts receivable | N/A | N/A | N/A | 316 | N/A |
| Other Working Capital | -53 | 1,064 | 786 | 120 | -199 |
| Other Operating Activity | 370 | 3,171 | 2,713 | 1,729 | 987 |
| Operating Cash Flow | $-2,101 | $-8,097 | $-6,314 | $-4,500 | $-2,288 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -196 | -187 | -182 | -50 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -106 | -45 |
| Other Investing Activity | -29 | -285 | -233 | -106 | -45 |
| Investing Cash Flow | $-29 | $-481 | $-420 | $-288 | $-95 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,922 | 1,668 | 1,668 | 1,668 | 1,668 |
| Financing Cash Flow | $4,922 | $1,668 | $1,668 | $1,668 | $1,668 |
| Beginning Cash Position | 2,352 | 9,261 | 9,261 | 9,261 | 9,261 |
| End Cash Position | 5,144 | 2,352 | 4,196 | 6,142 | 8,546 |
| Net Cash Flow | $2,792 | $-6,909 | $-5,066 | $-3,119 | $-715 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,101 | -8,097 | -6,314 | -4,500 | -2,288 |
| Capital Expenditure | 0 | -196 | -187 | -182 | -50 |
| Free Cash Flow | -2,101 | -8,293 | -6,501 | -4,682 | -2,339 |